P332: Presentation of an individual with a 3.3 Mb duplication in 3q13.2q13.31
Abstract
At age 24 he began daily creatine supplements (2.5 g) because of the low creatine findings on GMAPS. At age 26, his epilepsy medication was switched to levetiracetam 2000 mg/day with breakthrough seizures, and increased to 3000 mg/day after three weeks. His epilepsy remains uncontrolled and sodium valproate is being considered.
Fields of Study & Subjects
Genomic variations and chromosomal abnormalities
Epilepsy research and treatment
Genomics and Rare Diseases
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 103826–103826
- Publication date
- 1 January 2026
- Language
- EN